ES2192840T3 - Laxante osmotico no fermentado para tratar y prevenir cancer colorrectal. - Google Patents

Laxante osmotico no fermentado para tratar y prevenir cancer colorrectal.

Info

Publication number
ES2192840T3
ES2192840T3 ES99916994T ES99916994T ES2192840T3 ES 2192840 T3 ES2192840 T3 ES 2192840T3 ES 99916994 T ES99916994 T ES 99916994T ES 99916994 T ES99916994 T ES 99916994T ES 2192840 T3 ES2192840 T3 ES 2192840T3
Authority
ES
Spain
Prior art keywords
fermented
laxant
osmotic
treat
prevent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99916994T
Other languages
English (en)
Inventor
Denis E Corpet
Sylviane Tache
Geraldine Parnaud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Recherche Agronomique INRA
Ecole Nationale Veterinaire de Toulouse ENVT
Original Assignee
Institut National de la Recherche Agronomique INRA
Ecole Nationale Veterinaire de Toulouse ENVT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9813450A external-priority patent/FR2784896B1/fr
Application filed by Institut National de la Recherche Agronomique INRA, Ecole Nationale Veterinaire de Toulouse ENVT filed Critical Institut National de la Recherche Agronomique INRA
Application granted granted Critical
Publication of ES2192840T3 publication Critical patent/ES2192840T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Utilización de un laxante osmótico no fermentado como agente activo para la preparación de un medicamento destinado al tratamiento y/o a la prevención de los cánceres de colon y/o de recto.
ES99916994T 1998-10-27 1999-05-05 Laxante osmotico no fermentado para tratar y prevenir cancer colorrectal. Expired - Lifetime ES2192840T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9813450A FR2784896B1 (fr) 1998-10-27 1998-10-27 Utilisation du polyethylene-glycol dans le traitement et la prevention des cancers colorectaux
FR9903240A FR2784897B1 (fr) 1998-10-27 1999-03-16 Utilisation d'un laxatif osmotique non fermente dans le traitement et la prevention des cancers colorectaux

Publications (1)

Publication Number Publication Date
ES2192840T3 true ES2192840T3 (es) 2003-10-16

Family

ID=26234618

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99916994T Expired - Lifetime ES2192840T3 (es) 1998-10-27 1999-05-05 Laxante osmotico no fermentado para tratar y prevenir cancer colorrectal.

Country Status (13)

Country Link
US (1) US6939563B2 (es)
EP (1) EP1124566B1 (es)
AT (1) ATE232390T1 (es)
AU (1) AU758348B2 (es)
BR (1) BR9914794A (es)
CA (1) CA2347170C (es)
DE (1) DE69905384T2 (es)
DK (1) DK1124566T3 (es)
ES (1) ES2192840T3 (es)
FR (1) FR2784897B1 (es)
NZ (1) NZ511150A (es)
PT (1) PT1124566E (es)
WO (1) WO2000024407A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4535234B2 (ja) * 2001-10-29 2010-09-01 味の素株式会社 腸管洗浄製剤
RU2006140784A (ru) * 2004-04-20 2008-05-27 Дзе Юниверсити Оф Чикаго (Us) Терапевтическая система доставки, содержащая высокомолекулярное пэг-подобное соединение
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
US9198847B2 (en) * 2004-11-05 2015-12-01 The Procter & Gamble Company Personal care composition containing a non-guar galactomannan polymer derivative and an anionic surfactant system
AU2006244112B2 (en) * 2005-05-06 2011-02-17 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
AU2013202513B2 (en) * 2005-05-06 2016-03-24 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
US7495063B2 (en) * 2006-02-03 2009-02-24 Dow Global Technologies Inc. Reduced oligomer concentration in high purity polyalkylene glycols
EP2012804A4 (en) * 2006-04-24 2012-07-04 Bruce Medical Ab ANTICANCER AGENTS BASED ON POLYMERS
GB2447067A (en) * 2007-02-20 2008-09-03 Branko R Babic Alteration of osmotic gradients by polyhydroxy compounds
GB201018650D0 (en) * 2010-11-04 2010-12-22 Norgine Bv Methods and compositions
EA201692106A1 (ru) 2014-04-29 2017-04-28 КОЛОНАРИКОНСЕПТС ЭлЭлСи Пищевые продукты, системы, способы и наборы для замены электролитов
HK1247283A1 (zh) 2015-03-02 2018-09-21 科罗纳里康赛普茨有限责任公司 用於peg代谢物及peg分解产物检测的化合物及方法
EP3934663B1 (en) * 2019-03-05 2024-06-26 Dow Global Technologies LLC Polyethyleneglycol derivatives for use in treating cancer and/or inducing caspase activity
US12251399B2 (en) 2019-03-05 2025-03-18 Dow Global Technologies Llc Inducing caspase activity
CN113507933B (zh) 2019-03-05 2024-05-10 陶氏环球技术有限责任公司 诱导胱天蛋白酶活性

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930000861B1 (ko) * 1990-02-27 1993-02-08 한미약품공업 주식회사 오메프라졸 직장투여 조성물

Also Published As

Publication number Publication date
DK1124566T3 (da) 2003-06-02
CA2347170A1 (fr) 2000-05-04
NZ511150A (en) 2003-03-28
PT1124566E (pt) 2003-06-30
US20010051659A1 (en) 2001-12-13
EP1124566B1 (fr) 2003-02-12
CA2347170C (fr) 2011-09-20
WO2000024407A1 (fr) 2000-05-04
FR2784897A1 (fr) 2000-04-28
US6939563B2 (en) 2005-09-06
DE69905384T2 (de) 2003-11-27
ATE232390T1 (de) 2003-02-15
AU758348B2 (en) 2003-03-20
DE69905384D1 (de) 2003-03-20
EP1124566A1 (fr) 2001-08-22
BR9914794A (pt) 2001-07-10
AU3528399A (en) 2000-05-15
FR2784897B1 (fr) 2002-11-29

Similar Documents

Publication Publication Date Title
BR9914794A (pt) Laxativo osmótico, não fermentado, para tratar e prevenir o câncer cólon-retal
GB9807639D0 (en) Anti-inflammatory agents
NO20014662D0 (no) Fremgangsmåter og preparater for behandling av faste tumorer
MX9703694A (es) Tratamiento profilactico y terapeutico de la sensibilizacion e irritacion de la piel.
DE69826644D1 (de) Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker
PT1161248E (pt) Composição farmacêutica que contém uma fonte de nitrato e um agente acidificante destinada ao tratamento de feridas abertas e queimaduras
ATE370730T1 (de) Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung
ES2156840T1 (es) Medicamento que contiene polisulfato de pentosano e implante para tratar la fibrosis.
EA200200595A1 (ru) Лекарственная форма с высвобождением лекарства под действием гидрогеля
GB0013674D0 (en) Therapeutic use
ATE319447T1 (de) Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlund von neurologischen störungen
PT1079806E (pt) Preparacoes para a aplicacao de anti-inflamatorios, especialmente, agentes anti-septicos e/ou agentes de promocao da cura de feridas, no tracto respiratorio superior e/ou no ouvido
MY164077A (en) Compositions and uses of et743 for treating cancer
CA2411922A1 (en) Composition for pain mediation and apparatus and method of use thereof
CA2245890A1 (en) Use of an extract of cimicifuga racemosa
DK0856312T3 (da) Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme
ATE313334T1 (de) Behandlung von tumoren mit photodynamischer therapie
WO2001041747A3 (de) Pharmazeutische zubeteitung enthaltend zytostatika und electronenakzeptoren zur behandlung von krebs
MXPA01013460A (es) Formulaciones topicas que comprenden agentes de penetracion de la piel y uso de las mismas.
GEP20043231B (en) Resorcinol Composition
RU94024337A (ru) Антиметастатическое средство
AR027677A1 (es) Una composicion farmaceutica terapeutica que comprende camptotecina y ciclofosfamida para el tratamiento del cancer
SE9700617D0 (sv) New composition
PT874630E (pt) Terapia combinada de um inibidor da topoisomerase ii e um derivado da bis-dioxipiperazina
CA2306772A1 (en) Use of c18 to c26 aliphatic alcohols for the manufacture of a medicament in the treatment of hyperproliferative skin disorders